Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids ...

For centuries, music has been a balm for the soul — and, it turns out, for the body as well. From ancient healing rituals to ...

One participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous, which ...

U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...

The FDA has approved Journavx, a new non-opioid painkiller designed to treat moderate to severe acute pain. Unlike opioids, ...

The link between acetaminophen and elevated blood pressure is underappreciated. While less common, high blood pressure has ...

Will people with acute pain want a new painkiller whose list price is $15.50 a pill when a generic prescription drug is at ...

The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...

A new painkiller that is said to be free of addiction risks may be transformative for treatment of acute pain, according to local medical professionals. "I think it could be a potentially ...

Utilizing the company's electronic bookkeeping system, Haptonstall would assign the same number to a fraudulent check payable to herself and a legitimate check payable to one of the company's vendors, ...

The Food and Drug Administration approved Vertex Pharmaceuticals’ “Journavx” on Thursday, greenlighting the non-opioid ...

The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...